Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome

BACKGROUND: Polycystic ovary syndrome (PCOS) is a complex condition with high risk for dyslipidemia, dysglycemia, venous thromboembolism, cardiovascular disease and metabolic syndrome. Because the combined oral contraceptive (COC) use has also been associated with impaired fasting glucose, insulin r...

Descripción completa

Detalles Bibliográficos
Autor principal: de Medeiros, Sebastião Freitas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721684/
https://www.ncbi.nlm.nih.gov/pubmed/29216881
http://dx.doi.org/10.1186/s12958-017-0313-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721684/
https://www.ncbi.nlm.nih.gov/pubmed/29216881
http://dx.doi.org/10.1186/s12958-017-0313-y

Ejemplares similares